FDA
-
-
-
-
-
-
-
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure'
-
-
-
-
-
-
-
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
-
-
-
-
-
-
-
Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations
-
-
-
-
-
-
-
Cryoport Reports Record Results for Full Year 2020
-
-
-
-
-
-
-
Cryoport Revenue Grows 65% for First Quarter 2019
-
-
-
-
-
-
-
Cryoport Reports 56% Revenue Growth for Fiscal Year Ended December 31, 2017
-
-
-
-
-
-
-
Cryoport (CYRX) Says Novartis (NVS) Signed Agreement Contracting it Over Initial Three-year Term for Cryogenic Logistics Support of CTL019/CD19 CAR-T Cell Therapy
-
334,268 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


